Clinical Trials Directory

Trials / Completed

CompletedNCT03170999

Accurate Recognition of Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

Generation and Cognitive Testing of Informative and Suitable Items for a COPD Exacerbation Recognition Tool (CERT) for Detection of Exacerbations of COPD in Chinese Patients

Status
Completed
Phase
Study type
Observational
Enrollment
199 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

It has been observed that COPD exacerbations are under-reported in China. One of the reasons for this is Chinese subjects with COPD cannot describe the symptoms of exacerbation mentioned in English. Hence this study aims to create a tool called CERT that will help Chinese physicians and subjects with COPD to recognize and report exacerbations. The study will be carried out in 4 stages: item identification, cognitive briefing, item reduction and creation of final CERTs. Two CERTs will be prepared, one for subjects with COPD and another for physicians. A total of approximately 200 subjects will be included in the study and each subject will contribute to only one step.

Conditions

Interventions

TypeNameDescription
OTHERFocus group interviewFocus group interviews will take place to discuss the key domains of COPD exacerbation which then will be used in the formation of the draft item set.
OTHERDraft item setItems that form the draft item set will be subject to cognitive debriefing. Questions in the draft item set will collect information on whether the subjects with COPD have experienced that item during an exacerbation. Changes in this draft set will result in the formation of candidate item set.
OTHERCandidate item setItem reduction will be done using candidate item set and the subjects will be asked to respond to the candidate items on a 4-point scale in terms of how that item changed with the onset of the last episode. Item reduction will take into account frequency and magnitude of items, floor and ceiling items and consistency between regions. The candidate item set will then be used for generation of CERT.

Timeline

Start date
2018-01-29
Primary completion
2020-05-29
Completion
2020-05-29
First posted
2017-05-31
Last updated
2020-08-03

Locations

3 sites across 1 country: China

Source: ClinicalTrials.gov record NCT03170999. Inclusion in this directory is not an endorsement.

Accurate Recognition of Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) (NCT03170999) · Clinical Trials Directory